Navigation Links
Skin Cancer Prevention Update:
Date:11/8/2007

How New Research, a New Law and New Regulations Could Hold the Key to

Reducing Rising Skin Cancer Rates

NEW YORK, Nov. 8 /PRNewswire/ -- It is estimated that more than 1 million new cases of skin cancer will be diagnosed in the United States in 2007. While most skin cancers have excellent cure rates if detected and treated early, dermatologists stress that prevention is still the best medicine. In fact, dermatologists are hopeful that the recent introduction of a new law aimed at warning Americans about the risks of indoor tanning devices and new sunscreen regulations could prevent skin cancer in future generations and reduce the estimated $1.5 billion annual financial toll associated with treating non-melanoma skin cancers alone.

Speaking today at the American Academy of Dermatology's (Academy) Skin Academy, dermatologist Sandra I. Read, MD, FAAD, instructor of dermatology at Georgetown University School of Medicine in Washington, D.C., presented a summary of the latest developments in skin cancer prevention, including a new study of the most common locations of melanoma in each gender.

"Exposure to ultraviolet (UV) light, whether natural sunlight or artificial light used in indoor tanning, is a carcinogen that studies have shown directly increases a person's risk of developing skin cancer," said Dr. Read. "We're seeing an increase in skin cancers across all age groups, and the National Cancer Institute reports that melanoma is the second most common skin cancer in younger women aged 20-29. Because of this disturbing trend, lawmakers and regulatory agencies have proposed new initiatives to help protect Americans from this serious health threat."

Men, Women and Melanoma

Dr. Read discussed how clinical studies remain an invaluable tool in further understanding skin cancer. Now, a new study published online in the Journal of the American Academy of Dermatology in March 2007 examined whether the location where
'/>"/>

SOURCE American Academy of Dermatology
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. Survival differences by race most apparent in advanced stages of breast cancer
3. MRI finds breast cancer before it becomes dangerous
4. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
5. Pathway links inflammation, angiogenesis and breast cancer
6. Radiologists encouraged to look beyond cancer for clinically unseen diseases
7. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
8. Immune deficiency linked to a type of eye cancer
9. Drop in breast cancer incidence linked to hormone use, not mammograms
10. Breast cancer prevention practices vary across Canada
11. First biomarker discovered that predicts prostate cancer outcome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...epresentatives from the fitness,company Burn Mach... Shriners,Hospitals for Children in Chicago last ...nique, cause; The Burn Machine donated more than $...ent to the first ever Shriners,Wheelchair Bodybui...com/cgi-bin/prnh/20081203/CLW007 ) , "We k...
(Date:12/2/2008)...ersity, The Brigham and Women,s Hospital (Boston),...has found a new drug with the potential to allevia...k. , Dr Shantha Rajaratnam from Monash Universi...gical Medicine said tasimelteon, a drug which acts...ighly effective treatment for circadian rhythm sle...
(Date:12/2/2008)... Reminder, the nation,s leading,comprehensive pat... industry,technology today at Javits Center in Ne...ng and distributing video testimonials can be used... popular platforms such as YouTube, Google,Videos...with an effective,business strategy for increasin...
(Date:12/2/2008)... enterprise software and online services veteran i...scribers of Yugma,s instant web conferencing solut...RWEB) December 2, 2008 -- Yugma , the leading web... collaborate instantly using the Internet, announc...utive Officer. , , ,Vas has more than 20 years of ...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
...onmental Protection announced today that aerial sp...mosquito larvae in Philadelphia have been resched...oLex CG, which is not a chemical pesticide, but is...that targets mosquito and black fly larvae when ad...
...known as integrin alpha 7 (integrin 7) lead to unc...cer, report researchers at the University of Pitt...ed today in the Journal of the National Cancer Ins...a7 represents an important new target for cancer t...
...5N1 strain of bird flu has been detected among pou...n capital, officials said Wednesday. The virus w... Sungai Buloh area of Selangor state, said Kamarud...se control section at the Department of Veterinary...
...to stop feeling hungry, for researchers have devel...rmone which makes people feel full . Researchers d...aturally occurring hormone that is excreted during...he brain called MC4R. When the bodys need for food...
Other Medicine News:Health News:Rescheduled: Aerial Mosquito Treatment for Philadelphia 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 3Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 4Health News:Bird Flu Reappears in Malaysia 2
(Date:11/28/2008)...re/ -- German biotech company,Partec is expanding...ng and,AIDS patient follow-up diagnostics for dev... 2.5 million patient tests have been performed wit...low" system, supporting already,more than 1 milli...n of the,Partec innovation, the average cost of E...
(Date:11/26/2008)...d intelligent clinical applications take workflow ... , CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall...thcare ) highlights the ACUSON S2000(TM) Automate...rst multi-use, automated volume breast ultrasound ... Meeting of the Radiological Society of North Amer...
(Date:11/25/2008)...nding statin use broadly in wake of AHA-presented ...wswire/ -- JUPITER, a clinical trial suggesting ro...althy patients with elevated CRP, should not promp...to a national poll directed at health professional... poll conducted by medical news site MedPage Today...
(Date:11/25/2008)...ssess Survival of Patients Receiving Litx versus S...ellular Carcinoma , , BELLEVUE, Wash., Nov....(LSO) today announced the completion of enrollment...ion Therapy(TM) (Litx(TM)) as a treatment for unre...n as hepatoma or primary liver cancer. , , ...
Breaking Medicine Technology:German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Siemens Introduces New Standard of Care for Breast Ultrasound 2Siemens Introduces New Standard of Care for Breast Ultrasound 3Siemens Introduces New Standard of Care for Breast Ultrasound 4Siemens Introduces New Standard of Care for Breast Ultrasound 5Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 1Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 2Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 3Chemical liberated by leaky gut may allow HIV to infect the brain Einstein scientists find 25520 4Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 1Researchers study facial structures brain abnormalities to reveal formula for detection of autism 4511 2Signals from the Atlantic salmon highway 4508 1Signals from the Atlantic salmon highway 4508 2Signals from the Atlantic salmon highway 4508 3Signals from the Atlantic salmon highway 4508 4Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 1Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 2Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 3Medco Announces Research Collaboration with FDA Focused on Personalized Medicine 25512 4
... the Journal of Clinical Oncology -, NEW YORK, Jul...a,Phase II study - which will be published in the ...ncology (JCO) and are now,available as an Early Re...www.jco.org/">www.jco.org - demonstrate that,ixab...ional,compound, has activity in patients with meta...
... TMC125, an Investigational NNRTI,from Tibotec, YA...m two,ongoing Phase 3 studies (DUET-1 and DUET-2) ...h documented non-nucleoside reverse,transcriptase ...stance reached an undetectable viral load (defined...V-1 RNA copies/mL) with,TMC125 (etravirine), Tibot...
Other Medicine Technology:Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 2Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 3Study Shows Ixabepilone Demonstrated Clear Activity in Patients,with Metastatic Breast Cancer Resistant to Anthracycline, Taxane,and Capecitabine 4TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 2TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 3TMC125 Showed Significant Virologic Response at Week 24 in,Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3,Trials 4
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle.
Fixed smooth rod which slides on skin. Designated most popular model or size.
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size.
30 mm button end blade. Flat handle.
Medicine Products: